Industry News
Performance declining for Australia's maths and science students
Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA). [ + ]
US conjunctivitis treatment funded by the MRCF
Okogen, a developer of ophthalmic anti-infective drugs, has received $13m from the Medical Research Commercialisation Fund to advance its viral conjunctivitis treatment. [ + ]
Funding announced for six new research collaborations
Projects outcomes include the development of 3D-printed materials for the vision impaired, improved grain crop production through better weed control and innovations in advanced composite paints. [ + ]
Nominations open for Prime Minister's Prizes for Science 2018
The Prime Minister's Prizes for Science celebrate the achievements and successes of Australian scientists, teachers and innovators. [ + ]
3D scaffolds to grow muscle
Australian biomedical engineers have combined lab-made peptides with natural proteins and polymers to create a 3D 'hydrogel scaffold'. [ + ]
Imagion Biosystems appoints new VP of clinical research
Dr Farideh Bischoff will lead the clinical program for MagSense cancer detection technology, to achieve regulatory approval as a diagnostic device for the early detection of malignant tumour cells. [ + ]
100,000 Genomes Project reaches halfway milestone
The UK's 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes, just over five years after it was announced by then Prime Minister David Cameron. [ + ]
Merck acquires Aus biotech Viralytics
Merck has acquired Australian listed cancer research firm Viralytics in a $502 million deal. [ + ]
BOC to locally produce over 8000 specialty gases
BOC Australia, part of The Linde Group, has unveiled a new $20 million specialty gases production facility and $15 million robot cylinder automation system at its Western Sydney site. [ + ]
CRISPR-based DNA detective
A CRISPR-based genetic detective could lead to fast, reliable medical tests. [ + ]
Next-gen antibody shows promise as lung fibrosis treatment
A locally developed molecule called an 'i-body' serves as a powerful inhibitor of fibroblast migration in human lungs, providing promising evidence for a new treatment of lung fibrosis. [ + ]
Obesity-focused start-up attracts $7m MRCF investment
The MRCF has announced a $7 mllion investment in Cincera Therapeutics, a biotech company seeking to develop therapies targeting conditions relating to an unhealthy diet. [ + ]
Mice successfully immunised against multiple cancers
Injecting mice with iPSCs launched a strong immune response against breast, lung and skin cancers, as well as preventing relapse in animals that had tumours removed. [ + ]
Autoscribe launches in Australia
Software provider Autoscribe Informatics has launched in Adelaide, South Australia, to better service the needs of its current and future customers in Australia and New Zealand. [ + ]
Fluid intelligence supported by MD brain regions
New research suggests that the ability to think flexibly and to solve novel problems is supported by 'multiple-demand' (MD) brain regions. [ + ]
